Description

3,4-Dihydro-4-Oxo-5,6-Dimethyl-3-((5,7-Difluorobenzothiazol-2-Yl)Methyl)-1-Pyridazineacetic Acid CAS NO 140926-46-1 is a high-purity, advanced pharmaceutical intermediate featuring a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular design. It is primarily sought by research institutions and manufacturers in the pharmaceutical and biotechnology sectors engaged in drug discovery and development programs.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly for central nervous system (CNS) and anti-inflammatory targets.
• Biochemical Research: Used as a reference standard or a building block in medicinal chemistry for structure-activity relationship (SAR) studies.
• Agrochemical Development: Serves as a potential intermediate in the research and synthesis of new-generation herbicides or fungicides.
• Material Science Research: Investigated for the development of specialty chemicals, dyes, or organic electronic materials due to its benzothiazole core.

Basic Information

Product Name	3,4-Dihydro-4-Oxo-5,6-Dimethyl-3-((5,7-Difluorobenzothiazol-2-Yl)Methyl)-1-Pyridazineacetic Acid
CAS No.	140926-46-1
Molecular Formula	C₁₈H₁₅F₂N₃O₃S
Molecular Weight	391.39 g/mol
Synonyms	5,6-Dimethyl-3-((5,7-difluorobenzothiazol-2-yl)methyl)-4-oxo-1,4-dihydropyridazine-3-acetic acid; 3-((5,7-Difluoro-1,3-benzothiazol-2-yl)methyl)-5,6-dimethyl-4-oxo-1,4-dihydropyridazine-1-acetic acid; 140926-46-1; 5,6-Dimethyl-3-[(5,7-difluoro-1,3-benzothiazol-2-yl)methyl]-4-oxo-1,4-dihydropyridazine-1-acetic Acid; Difluorobenzothiazolylmethyl Dihydropyridazineacetic Acid Derivative
EINECS	Contact for details

Quality Control

Our 3,4-Dihydro-4-Oxo-5,6-Dimethyl-3-((5,7-Difluorobenzothiazol-2-Yl)Methyl)-1-Pyridazineacetic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) with detailed chromatographic data are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.